Trial Profile
Phase III trial of CJC 1134 PC in patients with type 2 diabetes mellitus.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Sep 2011
Price :
$35
*
At a glance
- Drugs Albenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Sep 2011 New trial record